Biomaterial-based Immunomodulation

Biomaterial-Based Immunomodulation is a therapeutic strategy that employs engineered biomaterials to selectively modulate immune cell activity and signaling within the tumor microenvironment, distinguishing it from systemic immunomodulation by enabling spatially localized, sustained, and tunable delivery of immunoregulatory cues.

458

Publications

28K

Citations

3.3K

Authors

784

Institutions

Publications per year

2017–2026

383

Authors

3.3K

  1. ZL
    Zhuang Liu

    Soochow University, China

    10 publications · 1.2K citations

    10

    h-index

  2. LC
    Liang Cheng

    Soochow University, China

    10 publications · 675 citations

    10

    h-index

  3. XZ
    Xian‐Zheng Zhang

    Wuhan University, China

    9 publications · 423 citations

    9

    h-index

  4. DM
    David Mooney

    Harvard University, United States

    9 publications · 1.1K citations

    9

    h-index

  5. JE
    Julia E. Babensee

    Georgia Institute of Technology, United States

    8 publications · 500 citations

    8

    h-index

1–5 of 3.3K

Venues

  1. Biomaterials

    35 publications · 2.3K citations

    28

    h-index

  2. ACS Nano

    25 publications · 2K citations

    23

    h-index

  3. Advanced Materials

    20 publications · 2.7K citations

    20

    h-index

  4. Advanced Functional Materials

    18 publications · 911 citations

    18

    h-index

  5. Journal of Controlled Release

    18 publications · 600 citations

    14

    h-index

1–5